J. B. Tuynman

Chemoprevention for colon cancer: New opportunities, fact or fiction? (2006)

Tuynman, J.B., Dullemen, H.M. Van, Mulder, C.J.J.

Colorectal cancer (CRC) is still a disease with a high incidence and mortality. Prevention of (pre-) cancerous lesions of CRC by endoscopic screening is promising, but costs are high and...

Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma (2005)

Tuynman, J.B., Buskens, C.J., Kemper, K., Offerhaus, G.J.A., Richel, D.J., ...

Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma (2005)

Tuynman, J.B., Buskens, C.J., Kemper, K., Offerhaus, G.J.A., Richel, D.J., ...

Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn (2005)

Löwenberg, M., Tuynman, J.B., Bilderbeek, J., Gaber, T., Buttgereit, F., ...

Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn (2005)

Löwenberg, M., Tuynman, J.B., Bilderbeek, J., Gaber, T., Buttgereit, F., ...

Laparoscopische resectie van coloncarcinoom (2004)

Tuynman, J.B., Bemelman, W.A.

COX-2 inhibition as a tool to treat and prevent colorectal cancer (2004)

Tuynman, J.B., Peppelenbosch, M.P., Richel, D.J.

Cyclo-oxygenase(COX)-2-remming bij de preventie en de behandeling van colorectaal carcinoom (2003)

Tuynman, J.B., Hulscher, J.B.F., Steller, E.Ph., Richel, D.J.

Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma

Tuynman, J B, Lagarde, S M, Richel, D J

Oesophageal adenocarcinoma is an aggressive malignancy with propensity for early lymphatic and haematogenous dissemination. Since conventional TNM staging does not provide accurate prognostic...